RE:RE:RE:RE:RE:RE:RE:Antibody-Drug-Conjugate (ADC) company reports patient death Yes, but this would take us back to Phase I and saftey run-in trial Noteable. There is no longer time for that. As Matt stated, once they get approved (and they have to find a payer and run a successful Ph III first), then they will consider post approval studies with other CPOIs' This could well be funded by Roche... but that is 4 years away... it ain't gonna happen.